GLP-1 drugs show promise for treating addiction across multiple substances

theconversation.com

GLP-1 drugs show significant promise in treating addiction to a wide range of substances, according to a large-scale study. A study of 600,000 people found GLP-1 drugs reduced substance use deaths by 50% and overdoses by 39% in those with existing addiction. They also lowered the risk of developing addiction. These drugs, originally for diabetes and obesity, may target a shared vulnerability in addiction circuitry, potentially revolutionizing treatment by addressing cravings across multiple substances.


With a significance score of 6.5, this news ranks in the top 0.1% of today's 30863 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: